Abstract:BACKGROUND:Aminoglycoside ototoxicity is one of the common health problems. Mitochondrial 12S rRNA mutations are one of the important causes of aminoglycoside ototoxicity. However, the incidences of 12S rRNA mutations associated with aminoglycoside ototoxicity are less known.METHODS:A total of 440 Chinese pediatric hearing-impaired subjects were recruited from two otology clinics in the Ningbo and Wenzhou cities of Zhejiang Province, China. These subjects underwent clinical, genetic evaluation and molecular analysis of mitochondrial 12S rRNA. Resultant mtDNA variants were evaluated by structural and phylogenetic analysis.RESULTS:The study samples consisted of 227 males and 213 females. The age of all participants ranged from 1 years old to 18 years, with the median age of 9 years. Ninety-eight subjects (58 males and 40 females) had a history of exposure to aminoglycosides, accounting for 22.3% cases of hearing loss in this cohort. Molecular analysis of 12S rRNA gene identified 41 (39 known and 2 novel) variants. The incidences of the known deafness-associated 1555A > G, 1494C > T and 1095T > C mutations were 7.5%, 0.45% and 0.91% in this entire hearing-impaired subjects, respectively, and 21.4%, 2% and 2% among 98 subjects with aminoglycoside ototoxicity, respectively. The structural and phylogenetic evaluations showed that a novel 747A > G variant and known 839A > G, 1027A > G, 1310C > T and 1413T > C variants conferred increased sensitivity to aminoglycosides or nonsyndromic deafness as they were absent in 449 Chinese controls and localized at highly conserved nucleotides of this rRNA. However, other variants were polymorphisms. Of 44 subjects carrying one of definite or putative deafness-related 12S rRNA variants, only one subject carrying the 1413T > C variant harbored the 235DelC/299DelAT mutations in the GJB2 gene, while none of mutations in GJB2 gene was detected in other 43 subjects.CONCLUSIONS:Mutations in mitochondrial 12S rRNA accounted for ~30% cases of aminoglycoside-induced deafness in this cohort. Our data strongly support the idea that the mitochondrial 12S rRNA is the hot spot for mutations associated with aminoglycoside ototoxicity. These data have been providing valuable information and technology to predict which individuals are at risk for ototoxicity, to improve the safety of aminoglycoside antibiotic therapy, and eventually to decrease the incidence of deafness.

Role of mitochondrial dysfunction and oxidative stress in sensorineural hearing loss

Mitochondrial 12S Rrna Mutations Associated with Deafness

Defects in Mitochondrial Ribosomal Biogenesis Cause Sensorineural Deafness

Mitochondrial Stress Engages E2F1 Apoptotic Signaling to Cause Deafness

Prevalence of Mitochondrial 12s Rrna Mutation Associated with Aminoglycoside Ototoxicity

Mitochondrial DNA mutations associated with aminoglycoside induced ototoxicity

Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss

Functional Characterization of the Mitochondrial 12S Rrna C1494T Mutation Associated with Aminoglycoside-Induced and Non-Syndromic Hearing Loss.

Mitochondrial DNA Mutations Associated with Aminoglycoside Ototoxicity

[Modifier Factors Influencing the Phenotypic Manifestation of the Deafness Associated Mitochondrial DNA Mutations].

Frequency and Spectrum of Mitochondrial 12S Rrna Variants in 440 Han Chinese Hearing Impaired Pediatric Subjects from Two Otology Clinics.

Mitochondrial Dysfunction and Sirtuins: Important Targets in Hearing Loss

Mitochondrial redox system: A key target of antioxidant therapy to prevent acquired sensorineural hearing loss

Mitochondrial dysfunction in hearing loss: Oxidative stress, autophagy and NLRP3 inflammasome

Advances in the Study of Etiology and Molecular Mechanisms of Sensorineural Hearing Loss

Novel Role of the Mitochondrial Protein Fus1 in Protection from Premature Hearing Loss via Regulation of Oxidative Stress and Nutrient and Energy Sensing Pathways in the Inner Ear

ROS-Induced Oxidative Damage and Mitochondrial Dysfunction Mediated by Inhibition of SIRT3 in Cultured Cochlear Cells

Novel Role of the Mitochondrial Protein Fus1 in Protection from Premature Hearing LossviaRegulation of Oxidative Stress and Nutrient and Energy Sensing Pathways in the Inner Ear

Potential role of modulating autophagy levels in sensorineural hearing loss

Progress on mechanisms of age-related hearing loss

Current development of patient-specific induced pluripotent stem cells harbouring mitochondrial gene mutations and their applications in the treatment of sensorineural hearing loss